--- title: blog (3) description: (3) --- [Skip to content](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/page/3#main-content) [![IPO\_PROPHET\_BLUE logo](https://blog.ipoprophet.com/hs-fs/hubfs/IPO_PROPHET_BLUE%20logo.png?width=2973&height=302&name=IPO_PROPHET_BLUE%20logo.png)](https://www.IPOProphet.com) - [Login](https://app.ipoprophet.com/login) Open main navigation Close main navigation - [Login](https://app.ipoprophet.com/login) [Subscribe to our Newsletter](https://share.hsforms.com/1xXldKrGiQBCbNmtOz6j4Jwq3cu4) [Go Back to Home](http://www.ipoprophet.com/) [Go Back to Blog](http://www.ipoprophet.com/blog) [![](https://blog.ipoprophet.com/hubfs/Attovia%20logo.png)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/attovia-therapeutics-atto-delivers-strong-ipo-debut-as-investors-reward-next-generation-immunology-platform) [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [Attovia Therapeutics](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/attovia-therapeutics) ## [Attovia Therapeutics (ATTO) Delivers Strong IPO Debut as Investors Reward Next-Generation Immunology Platform](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/attovia-therapeutics-atto-delivers-strong-ipo-debut-as-investors-reward-next-generation-immunology-platform) ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Aug 5, 2026, 5:04:26 PM [![](https://blog.ipoprophet.com/hubfs/Latigo%20Bio%20Logo.png)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/latigo-biotherapeutics-ltgo-eyes-272-million-ipo-to-advance-next-generation-non-opioid-pain-medicines) [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [Biotech](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/biotech), [Latigo Biotherapeutics](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/latigo-biotherapeutics), [Biotherapeutics](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/biotherapeutics) ## [Latigo Biotherapeutics (LTGO) Eyes $272 Million IPO to Advance Next-Generation Non-Opioid Pain Medicines](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/latigo-biotherapeutics-ltgo-eyes-272-million-ipo-to-advance-next-generation-non-opioid-pain-medicines) ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Aug 3, 2026, 5:13:40 PM Thousand Oaks, California-based Latigo Biotherapeutics has filed for a Nasdaq IPO seeking to raise a... [![](https://blog.ipoprophet.com/hubfs/Blossomhill%20therapeutics%20Thumbnail%202.jpg)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/blossomhill-therapeutics-blsm-targets-125-million-ipo-to-advance-precision-oncology-pipeline-built-on-next-generat-1785786987211) [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [Blossomhill Therapeutics](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/blossomhill-therapeutics) ## [BlossomHill Therapeutics (BLSM) Targets $125 Million IPO to Advance Precision Oncology Pipeline Built on Next-Generation Small Molecule Design](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/blossomhill-therapeutics-blsm-targets-125-million-ipo-to-advance-precision-oncology-pipeline-built-on-next-generat-1785786987211) ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Aug 3, 2026, 4:00:36 PM San Diego-based BlossomHill Therapeutics has filed for a Nasdaq IPO seeking to raise approximately $... [![](https://blog.ipoprophet.com/hubfs/Attovia%20Thumbnail.jpg)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/attovia-therapeutics-atto-targets-200-million-ipo-to-advance-next-generation-biologics-for-immune-mediated-diseases) [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [Attovia Therapeutics](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/attovia-therapeutics) ## [Attovia Therapeutics (ATTO) Targets $200 Million IPO to Advance Next-Generation Biologics for Immune-Mediated Diseases](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/attovia-therapeutics-atto-targets-200-million-ipo-to-advance-next-generation-biologics-for-immune-mediated-diseases) ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Jul 31, 2026, 3:12:40 PM Attovia Therapeutics (NASDAQ: ATTO) has filed to raise approximately $200 million through an initial... [![](https://blog.ipoprophet.com/hubfs/Braveheart%20Bio%20Thumbnail.jpg)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/braveheart-bio-brve-sets-terms-for-300-million-ipo-to-advance-next-generation-therapy-for-hypertrophic-cardiomyopathy) [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [Braveheart Bio](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/braveheart-bio) ## [Braveheart Bio (BRVE) Sets Terms for $300 Million IPO to Advance Next-Generation Therapy for Hypertrophic Cardiomyopathy](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/braveheart-bio-brve-sets-terms-for-300-million-ipo-to-advance-next-generation-therapy-for-hypertrophic-cardiomyopathy) ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Jul 31, 2026, 1:41:24 PM Braveheart Bio (NASDAQ: BRVE) has filed to raise approximately $300 million through an initial publi... [![](https://blog.ipoprophet.com/hubfs/undefined-1.png)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/consumer-ipos-fail-to-gain-traction-as-jersey-mikes-and-reformation-deliver-mixed-debuts) [Jersey Mikes](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/jersey-mikes), [Reformation](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/reformation) ## [Consumer IPOs Fail to Gain Traction as Jersey Mike's and Reformation Deliver Mixed Debuts](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/consumer-ipos-fail-to-gain-traction-as-jersey-mikes-and-reformation-deliver-mixed-debuts) ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Jul 30, 2026, 5:10:38 PM After a strong stretch for the U.S. IPO market, Thursday's debut of Jersey Mike's (JMKE) and Reforma... [![](https://blog.ipoprophet.com/hubfs/Apnimed%20thumbnail.jpg)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/apnimed-apmd-eyes-150-million-ipo-as-fda-review-puts-oral-sleep-apnea-therapy-within-reach) [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [Apnimed](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/apnimed) ## [Apnimed (APMD) Eyes $150 Million IPO as FDA Review Puts Oral Sleep Apnea Therapy Within Reach](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/apnimed-apmd-eyes-150-million-ipo-as-fda-review-puts-oral-sleep-apnea-therapy-within-reach) ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Jul 27, 2026, 2:00:50 PM [![](https://blog.ipoprophet.com/hubfs/Reformation%20Thumbnail.jpg)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/reformation-ref-brings-sustainable-fashion-leader-to-nyse-in-225-million-ipo) [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [Reformation](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/reformation) ## [Reformation (REF) Brings Sustainable Fashion Leader to NYSE in $225 Million IPO](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/reformation-ref-brings-sustainable-fashion-leader-to-nyse-in-225-million-ipo) ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Jul 23, 2026, 4:09:31 PM [![](https://blog.ipoprophet.com/hubfs/Jersey_Mikes_logo.svg.webp)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/jersey-mikes-jmke-targets-1.0-billion-ipo-as-leading-franchise-sandwich-chain-enters-the-public-markets) [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [Jersey Mikes](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/jersey-mikes) ## [Jersey Mike's (JMKE) Targets $1.0 Billion IPO as Leading Franchise Sandwich Chain Enters the Public Markets](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/jersey-mikes-jmke-targets-1.0-billion-ipo-as-leading-franchise-sandwich-chain-enters-the-public-markets) ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Jul 21, 2026, 3:39:05 PM [![](https://blog.ipoprophet.com/hubfs/Scribe%20Therapeutics%20Thumbnail.jpg)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/scribe-therapeutics-sctx-targets-100-million-ipo-to-advance-next-generation-crispr-medicines-for-cardiovascular-disease) [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [Scribe Therapeutics](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/scribe-therapeutics) ## [Scribe Therapeutics (SCTX) Targets $100 Million IPO to Advance Next-Generation CRISPR Medicines for Cardiovascular Disease](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/scribe-therapeutics-sctx-targets-100-million-ipo-to-advance-next-generation-crispr-medicines-for-cardiovascular-disease) ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Jul 20, 2026, 12:37:27 PM Scribe Therapeutics (NASDAQ: SCTX) has filed for an initial public offering of 7.15 million shares p... [First](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y) [Prev](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/page/2) [1](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y) [2](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/page/2) [3](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/page/3) [4](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/page/4) [5](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/page/5) [Next](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/page/4) [Last](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/page/24) ### Subscribe to our Newsletter Email [linkedin-in icon](https://www.linkedin.com/company/ipo-prophet-software/) [X Twitter icon](https://www.x.com/ipoprophet) --- [![IPO\_PROPHET\_WHITE-2](https://blog.ipoprophet.com/hs-fs/hubfs/IPO_PROPHET_WHITE-2.png?width=800&height=250&name=IPO_PROPHET_WHITE-2.png "IPO_PROPHET_WHITE-2")](http://www.ipoprophet.com) NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE. Copyright © 2025